CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

cbl-514

Small moleculeexperimental

Clinical trial activity

12 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
11
Phase 3
1
Phase 4
0

Earliest trial started Nov 27, 2018 (NCT04699669)

Timeline

2010s

  1. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2025

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07140939Phase 3Sep 30, 2025Caliway Biopharmaceuticals Co., Ltd.
NCT06303570Phase 2Dec 31, 2024Caliway Biopharmaceuticals Co., Ltd.
NCT06005441Phase 2Nov 10, 2023Caliway Biopharmaceuticals Co., Ltd.
NCT05736107Phase 2May 30, 2023Caliway Biopharmaceuticals Co., Ltd.
NCT05836779Phase 2May 10, 2023Caliway Biopharmaceuticals Co., Ltd.
NCT05632926Phase 2Jan 9, 2023Caliway Biopharmaceuticals Co., Ltd.
NCT05387733Phase 2Oct 3, 2022Caliway Biopharmaceuticals Co., Ltd.
NCT05234736Phase 2Feb 11, 2022Caliway Biopharmaceuticals Co., Ltd.
NCT04897412Phase 2Oct 31, 2021Caliway Biopharmaceuticals Co., Ltd.
NCT04575467Phase 2Nov 30, 2020Caliway Biopharmaceuticals Co., Ltd.
NCT04698642Phase 2Feb 3, 2020Caliway Biopharmaceuticals Co., Ltd.
NCT04699669Phase 1Nov 27, 2018Caliway Biopharmaceuticals Co., Ltd.
Showing 12 of 12 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Caliway Biopharmaceuticals Co., Ltd.For profit121232018
1 organizations
Page 1 / 1